Scholarly Index
Leslie Amass
Pfizer (United States); 4,155 total citations; 86 total publications; best world rank #200
Pfizer (United States)
4,155Total citations
86Total publications
36H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Opioid Use Disorder Treatment | Lifetime | 371 | US 256 | 96.49 |
| Amyloidosis: Diagnosis, Treatment, Outcomes | Lifetime | 438 | US 193 | 95.38 |
| Amyloidosis: Diagnosis, Treatment, Outcomes | 2021-2025 | 200 | US 75 | 92.64 |
| Eosinophilic Disorders and Syndromes | 2021-2025 | 402 | US 161 | 85.73 |
| Dermatological and Skeletal Disorders | 2021-2025 | 200 | US 54 | 72.70 |
| Sarcoidosis and Beryllium Toxicity Research | 2021-2025 | 793 | US 234 | 73.27 |
| IgG4-Related and Inflammatory Diseases | 2021-2025 | 663 | US 101 | 49.74 |